Multidrug-resistant tuberculosis (MDR-TB) treatment in the UK: a study of injectable use and toxicity in practice (Q39742683)

14 September 2017

title

Multidrug-resistant tuberculosis (MDR-TB) treatment in the UK: a study of injectable use and toxicity in practice (English)

1 reference

multidrug-resistant tuberculosis

14 September 2017

0 references

multiple drug resistance

1 reference

based on heuristic

inferred from title

1 reference

1 reference

14 September 2017

Graham S Cooke

0 references

Thomas S Harrison

0 references

Ann Sturdy

1 reference

14 September 2017

Anna Goodman

1 reference

14 September 2017

Ricardo J José

1 reference

14 September 2017

Angela Loyse

1 reference

14 September 2017

Marie O'Donoghue

1 reference

14 September 2017

Martin J Dedicoat

1 reference

14 September 2017

Laurence John

1 reference

14 September 2017

Marc Lipman

1 reference

14 September 2017

language of work or name

English

0 references

publication date

3 June 2011

1 reference

Journal of Antimicrobial Chemotherapy

14 September 2017

published in

1 reference

14 September 2017

1 reference

14 September 2017

1 reference

14 September 2017

page(s)

1815-1820

1 reference

Rapid molecular detection of rifampicin resistance facilitates early diagnosis and treatment of multi-drug resistant tuberculosis: case control study

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR221

Extensively drug-resistant tuberculosis in the UK: 1995 to 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR221

Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR221

The diarylquinoline TMC207 for multidrug-resistant tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR221

Aminoglycoside ototoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR221

Aminoglycoside toxicity: daily versus thrice-weekly dosing for treatment of mycobacterial diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR221

Familial aggregation of streptomycin ototoxicity: autosomal dominant inheritance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR221

Mitochondrial ribosomal RNA mutation associated with both antibiotic–induced and non–syndromic deafness

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR221

Audiologic monitoring of multi-drug resistant tuberculosis patients on aminoglycoside treatment with long term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR221

Comparison of bactericidal activities of streptomycin, amikacin, kanamycin, and capreomycin against Mycobacterium avium and M. tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR221

In-vitro activities of aminoglycoside-aminocyclitols against mycobacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR221

In vitro activities of fourteen antimicrobial agents against drug susceptible and resistant clinical isolates of Mycobacterium tuberculosis and comparative intracellular activities against the virulent H37Rv strain in human macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR221

Hypokalemia among patients receiving treatment for multidrug-resistant tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR221

A rapid method for detection of five known mutations associated with aminoglycoside-induced deafness

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR221

Investigation of mitochondrial sequence variants associated with aminoglycoside-induced ototoxicity in South African TB patients on aminoglycosides

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR221

21 January 2018

Identifiers

DOI

10.1093/JAC/DKR221

1 reference

14 September 2017

1 reference